Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.69 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.69 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.69 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.69 |
| ▸ | DRD4 | P21917 | 2/20 | 0.69 |
| ▸ | HTR2B | P41595 | 2/20 | 0.69 |
| ▸ | USP2 | O75604 | 1/20 | 0.69 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.69 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.69 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.69 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.69 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.69 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.69 |
| ▸ | DRD1 | P21728 | 1/20 | 0.69 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11182497 | 0.87 | KDM4E (0.56) | ALDH1A1SIGMAR1CYP2C19ADRA2AADRA2B | |
| SCHEMBL10623002 | 0.86 | ALDH1A1 (0.63) | ALDH1A1SIGMAR1CYP2C19ADRA2AADRA2B | |
| SCHEMBL8800836 | 0.86 | ALDH1A1 (0.60) | ALDH1A1SIGMAR1CYP2C19ADRA2AADRA2B | |
| SCHEMBL10620994 | 0.84 | SIGMAR1 (0.55) | ALDH1A1SIGMAR1CYP2C19ADRA2AADRA2B | |
| Hydrochloric Acid SCHEMBL11246914 | 0.84 | KDM4E (0.64) | ALDH1A1SIGMAR1CYP2C19ADRA2AADRA2B | |
| SCHEMBL10620988 | 0.84 | CYP2C19 (0.62) | ALDH1A1SIGMAR1CYP2C19ADRA2AADRA2B | |
| SCHEMBL10623055 | 0.84 | ALDH1A1 (0.58) | ALDH1A1SIGMAR1CYP2C19ADRA2AADRA2B | |
| SCHEMBL10621063 | 0.84 | ALDH1A1 (0.58) | ALDH1A1SIGMAR1CYP2C19ADRA2AADRA2B | |
| Hydrochloric Acid SCHEMBL11704225 | 0.83 | MAPK1 (0.59) | ALDH1A1SIGMAR1CYP2C19ADRA2AADRA2B | |
| Hydrochloric Acid SCHEMBL11704057 | 0.83 | MAPK1 (0.59) | ALDH1A1SIGMAR1CYP2C19ADRA2AADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-63126883-A | — | — | None | — | — | JP | disclosed |
| JP-63126882-A | — | — | None | — | — | JP | disclosed |
| US-10919917-B2 | Silylated derivatives of aromatic heterocycles | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2021-02-16 | — | — | US | disclosed |
| US-9169265-B2 | Process for preparing pharmaceutical compounds and intermediate compounds | EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENYTARSASAG (HU) | 2015-10-27 | — | — | US | disclosed |
| US-9169265-B2 | Process for preparing pharmaceutical compounds and intermediate compounds | EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENYTARSASAG (HU) | 2015-10-27 | — | — | US | disclosed |
| CN-103694251-A | Novel preparation process of prasugrel hydrochloride | NANJING JIANCHENG MEDICINE SCIENCE & TECHNOLOGY CO LTD | 2014-04-02 | — | — | CN | disclosed |
| US-20130030183-A1 | PROCESS FOR PREPARING A PHARMACEUTICAL COMPOUND | EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENYTARSASAG (HU) | 2013-01-31 | — | — | US | disclosed |
| US-20130030183-A1 | PROCESS FOR PREPARING A PHARMACEUTICAL COMPOUND | EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENYTARSASAG (HU) | 2013-01-31 | — | — | US | disclosed |
| US-20120330018-A1 | PROCESS FOR PREPARING PHARMACEUTICAL COMPOUNDS AND INTERMEDIATE COMPOUNDS | EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENYTARSASAG (HU) | 2012-12-27 | — | — | US | disclosed |
| US-20120330018-A1 | PROCESS FOR PREPARING PHARMACEUTICAL COMPOUNDS AND INTERMEDIATE COMPOUNDS | EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENYTARSASAG (HU) | 2012-12-27 | — | — | US | disclosed |
| US-20040053913-A1 | Process for preparing 6-alkylidene penem derivatives | WYETH | 2004-03-18 | — | — | US | disclosed |
| WO-2003093279-A1 | BICYCLIC 6-ALKYLIDENE-PENEMS AS ß-LACTAMASES INHIBITORS | WYETH (US) | 2003-11-13 | — | — | WO | disclosed |
| WO-2003093277-A1 | PROCESS FOR PREPARING 6-ALKYLIDENE PENEM DERIVATIVES | WYETH (US) | 2003-11-13 | — | — | WO | disclosed |
| US-4749692-A | COMBINATION OF SULFINPYRAZONE AND PYRIDINE DERIVATIVE | SANOFI, S.A. (FR) | 1988-06-07 | — | — | US | disclosed |
| JP-S63126883-A | 5-BENZYL-4,5,6,7-TETRAHYDRO-2H-THIENO(3,2-C)PYRIDIN-3-ONE DERIVATIVE AND PRODUCTION THEREOF | ZOKI SEIKAGAKU KENKYUSHO:KK | 1988-05-30 | — | — | JP | disclosed |
| JP-S63126882-A | PRODUCTION OF 5-BENZYL-4,5,6,7-TETRAHYDROTHIENO(3,2-C)PYRIDINE DERIVATIVE | ZOKI SEIKAGAKU KENKYUSHO:KK | 1988-05-30 | — | — | JP | disclosed |
| US-4537894-A | ADMINISTERING SULFINPYRAZONE AND PYRIDINE DERIVATIVE | SANOFI, S.A. (FR) | 1985-08-27 | — | — | US | disclosed |
| US-4515951-A | OXIDATION OF BORONIC ACID DERIVATIVE, HYDROLYSIS | SANOFI (FR) | 1985-05-07 | — | — | US | disclosed |
| US-4464377-A | SYNERGISTIS BETA-ADRENERGIC BLOCKERS AND TICLOPIDINE | SANOFI-SYNTHELABO (FR) | 1984-08-07 | — | — | US | disclosed |
| US-4193997-A | ANTICOAGULANT, HTROMBOSIS, ANALGESICS, ANTIINFLAMMATORY | PARCOR (FR) | 1980-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130030183-A1 | PROCESS FOR PREPARING A PHARMACEUTICAL COMPOUND | CYP3A5, CYP2C19, CYP4B1 | ALDH1A1 175/4885SIGMAR1 2240/4885CYP2C19 2/4885 |
| US-20120330018-A1 | PROCESS FOR PREPARING PHARMACEUTICAL COMPOUNDS AND INTERMEDIATE COMPOUNDS | CYP3A5, CYP4B1, P2RY6 | ALDH1A1 688/4885SIGMAR1 3875/4885CYP2C19 9/4885 |
| US-10919917-B2 | Silylated derivatives of aromatic heterocycles | KCNH1, KCNH3, HNRNPH3 | ALDH1A1 1869/4885SIGMAR1 233/4885CYP2C19 2389/4885 |
| US-20040053913-A1 | Process for preparing 6-alkylidene penem derivatives | PGM2, BPGM, MRPL21 | ALDH1A1 998/4885SIGMAR1 3564/4885CYP2C19 159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.